source
- Evaluating Observational and Propensity Matched Studies in Metastatic Castration Sensitive Prostate Cancer (mCSPC)Experts weigh real‑world evidence for prostate cancer drug comparisons, explaining bias risks, data quality, and how it complements trials.onclive · 2mo ago↗ source
- Reigniting Your Curiosity During FellowshipMegan M. Dupuis, MD, PhD, discusses how oncology fellows can keep their personal and professional curiosities alive during fellowship.onclive · 2mo ago↗ source
- STAT+: FDA to reconsider treatment for rare cancer after its surprise rejectionThe companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.STAT · 2mo ago↗ source